Zhang Runjiao, Dong Li, Yu Jinpu
Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Caner, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China.
Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Front Oncol. 2021 Jan 15;10:544579. doi: 10.3389/fonc.2020.544579. eCollection 2020.
Driver oncogene alterations have always been one of leading causes in the process of occurrence and development of tumors. And the effects of driver oncogene alterations on tumorigenesis and progression in different kinds of tumors have been studied heatedly. And the roles that the driver oncogenes alterations play have been elucidated clearly in previous studies. The phenomenon of concomitant driver oncogenes mutations and driver genes fusions has gained much concentration in the past two decades. And a growing number of studies reported this phenomenon, either coexistence or mutually exclusivity. Here we reviewed on the phenomenon of concomitant mutations in three common types of carcinomas-lung cancer, thyroid cancer, and leukemia, which have been studied relatively more detailed and more general compared with others.
驱动癌基因改变一直是肿瘤发生发展过程中的主要原因之一。驱动癌基因改变对不同类型肿瘤的肿瘤发生和进展的影响已得到深入研究。在以往的研究中,驱动癌基因改变所起的作用已被明确阐明。在过去二十年中,驱动癌基因共突变和驱动基因融合的现象备受关注。越来越多的研究报道了这种现象,包括共存或互斥。在此,我们综述了三种常见癌症——肺癌、甲状腺癌和白血病中的共突变现象,与其他癌症相比,这三种癌症的相关研究相对更详细、更普遍。